Loading data for APVO — first visit, this takes a few seconds.
Aptevo Therapeutics Inc. (APVO)
NasdaqCM: APVO
· 即時價格 · USD
2.37
-0.05 (-2.07%)
收盤價： Sep 10, 2026, 8:00 PM
1.77
-3.28%
盤前: 4:11 AM
股價、關鍵數字和最新消息，都在這一頁。
Aptevo Therapeutics Inc.（APVO）股價、分析與資料
無可用資料
| 買價 | 1.78 |
| 市值 | 3.31M |
| 營收 (ttm) | n/a |
| 淨利（ttm） | -26.5M |
| 1.61 | |
| 452.91 | |
| 0 | |
| -0.18 | |
| P/B (ttm) | 0.43 |
| P/S (ttm) | 0.00 |
| 財報日期 | n/a |
| 賣價 | 2.99 |
| 成交量 | 20,992 |
| 20 日平均成交量 | 56,911 |
| 開盤價 | 2.46 |
| 前收盤價 | 2.42 |
| 當日區間 | 2.32 - 2.46 |
| 52 週範圍 | 2.30 - 48.78 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 APVO
Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical bloo...
完整的公司簡介財報驚奇
Aptevo Therapeutics 已於 Aug 14, 2026 公布季度財報：
- 營收為 $0 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 -5.31 超出預期 0.89, 年增 99.66% 成長.
